Therapy‐related, mixed‐lineage leukaemia translocation‐positive, monoblastic myeloid sarcoma of the uterus
AUTOR(ES)
Pullarkat, Vinod
FONTE
BMJ Group
RESUMO
Myeloid sarcomas are tumour masses of myeloid leukaemic cells at extramedullary sites. These tumours can, on occasion, occur without concurrent or antecedent leukaemia. Myeloid sarcomas have been described at unusual locations including the female genital tract. An unusual case of therapy‐related acute myeloid leukaemia (t‐AML) presenting as isolated monoblastic myeloid sarcoma of the uterus in a patient who had received adjuvant chemotherapy for breast cancer is presented. Fluorescence in situ hybridisation analysis performed on paraffin‐wax‐embedded tumour tissue revealed a mixed‐lineage leukaemia (MLL) gene rearrangement, supporting the association of this malignancy with prior chemotherapy. This case illustrates that t‐AML can rarely present as isolated extramedullary tumours, and the detection of specific chromosomal abnormalities in these myeloid sarcomas can be useful for risk assessment and guiding definitive therapy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1994540Documentos Relacionados
- Novel SWI/SNF Chromatin-Remodeling Complexes Contain a Mixed-Lineage Leukemia Chromosomal Translocation Partner
- Chromatin control of gene expression: Mixed-lineage leukemia methyltransferase SETs the stage for transcription
- Mixed-Lineage Kinase 3 Delivers CD3/CD28-Derived Signals into the IκB Kinase Complex
- Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product.
- 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
